Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2011; 17(30): 3479-3486
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3479
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3479
Table 3 Distribution of albumin consumption and cost among clinical indications in 2008
| Vials (number)(%) | Cost (euros) | Patients (number)(%) | Vials/patients (number) | Cost/patient (euros) | |
| Cirrhosis | 19 871 (52) | 534.532 | 807 (36.3) | 24.6 | 662 |
| Major surgery | 6196 (16.2) | 166.982 | 495 (22.2) | 12.5 | 337 |
| Shock | 5069 (13.3) | 136.558 | 447 (20) | 11.3 | 305 |
| Enteric disease | 2982 (7.8) | 80.215 | 146 (6.5) | 20.4 | 549 |
| Plasmapheresis | 2333 (6.1) | 62.757 | 54 (2.4) | 43.2 | 1162 |
| Mars | 196 (0.5) | 5.272 | 6 (0.2) | 32.6 | 878 |
| Others1 | 201 (0.5) | 5353.000 | 149 (6.7) | 7.1 | 260 |
| Extra-protocol | 1240 (3.7) | 33.418 | 119 (5.3) | 10.5 | 281 |
- Citation: Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486
- URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3479.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3479